AVITA Medical Profit Margin

AVITA Medical (RCEL) currently reports a profit margin of -56.96% as of June 2026. That compares with -68.87% in the prior-year period — up 17.3% year over year. That is below the sector sector average of 13.2%. Use the charts on this page to explore AVITA Medical's profit margin history and peer comparisons.

AVITA Medical's profit margin increased from -68.87% to -56.96% — a 17.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AVITA Medical's profit margin of -56.96% is lower than the its sector sector average of 13.2%. That is roughly 531.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but AVITA Medical's current -56.96% should be judged against industry norms (sector average: 13.2%) and against RCEL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -56.96%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.2%. From there, open related valuation or income-statement pages for AVITA Medical, and consider following RCEL for alerts when major investors trade the stock.